Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Current Deferred Revenue (2016 - 2025)

Healthstream (HSTM) has disclosed Current Deferred Revenue for 16 consecutive years, with $88.4 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue rose 4.97% to $88.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $88.4 million through Dec 2025, up 4.97% year-over-year, with the annual reading at $88.4 million for FY2025, 4.97% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $88.4 million at Healthstream, up from $85.7 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $102.0 million in Q1 2025, with the low at $73.8 million in Q4 2021.
  • Average Current Deferred Revenue over 5 years is $85.2 million, with a median of $83.9 million recorded in 2023.
  • Peak annual rise in Current Deferred Revenue hit 22.14% in 2021, while the deepest fall reached 9.07% in 2021.
  • Over 5 years, Current Deferred Revenue stood at $73.8 million in 2021, then rose by 7.66% to $79.5 million in 2022, then rose by 5.23% to $83.6 million in 2023, then grew by 0.72% to $84.2 million in 2024, then grew by 4.97% to $88.4 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $88.4 million, $85.7 million, and $88.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.